1 report

The company' s product portfolio comprises both marketed and pipeline products for the treatment of a wide range of diseases in the areas of urology, transplantation, immune deficiency, infectious diseases, cancer, neuroscience, and metabolic diseases, among others.

  • Autoimmune Disease
  • United States
  • World
  • Product Initiative
  • CompleGen, Inc.